Correction: Silibinin Inhibits HIV-1 Infection by Reducing Cellular Activation and Proliferation

Correction: Silibinin Inhibits HIV-1 Infection by Reducing Cellular Activation and Proliferation

Bibliographic Details
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2012-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3491913/?tool=EBI

Similar Items

Correction: Silibinin Inhibits HIV-1 Infection by Reducing Cellular Activation and Proliferation.
by: Janela McClure, et al.
Published: (2012-01-01)

Silibinin inhibits HIV-1 infection by reducing cellular activation and proliferation.
by: Janela McClure, et al.
Published: (2012-01-01)

Silibinin reduces cell proliferation and migration via EMT pathway in TFK-1 cell line
by: Özel Yetkin Merve, et al.
Published: (2023-12-01)

Inhibition of Phagocytosis by Silibinin in Mouse Macrophages
by: Kyung-Hoon Sun, et al.
Published: (2023-10-01)

Downregulation of Jumonji-C domain-containing protein 5 inhibits proliferation by silibinin in the oral cancer PDTX model.
by: Cheng-Yu Yang, et al.
Published: (2020-01-01)

Silibinin Promotes Cell Proliferation Through Facilitating G1/S Transitions by Activating Drp1-Mediated Mitochondrial Fission in Cells
by: Yanting You, et al.
Published: (2020-08-01)

Silibinin Inhibits Cell Ferroptosis and Ferroptosis-Related Tissue Injuries
by: Wentao Duan, et al.
Published: (2023-12-01)

Silibinin Inhibits NSCLC Metastasis by Targeting the EGFR/LOX Pathway
by: Xiaoying Hou, et al.
Published: (2018-02-01)

Effect of silibinin in reducing inflammatory pathways in in vitro and in vivo models of infection-induced preterm birth.
by: Ratana Lim, et al.
Published: (2014-01-01)

The Impact of Cellular Proliferation on the HIV-1 Reservoir
by: Maria C. Virgilio, et al.
Published: (2020-01-01)

Silibinin alleviates intestinal inflammation via inhibiting JNK signaling in Drosophila
by: La Yan, et al.
Published: (2023-09-01)

Silibinin reduces in vitro methane production by regulating the rumen microbiome and metabolites
by: Rui Liu, et al.
Published: (2023-08-01)

Targeting the hallmarks of cancer: the effects of silibinin on proliferation, cell death, angiogenesis, and migration in colorectal cancer
by: Saba Sameri, et al.
Published: (2021-05-01)

Silibinin and non-melanoma skin cancers
by: Ram Raj Prasad, et al.
Published: (2020-05-01)

Silibinin Inhibits Cell Invasion through the Inhibition of MMPs, p-p38, and IL-1β in Human Fibrosarcoma Cells
by: Ah In Jo, et al.
Published: (2023-04-01)

Silibinin, a potential fasting mimetic, inhibits hepatocellular carcinoma by triggering extrinsic apoptosis
by: Biying Xiao, et al.
Published: (2024-01-01)

An Evaluation of the In Vitro Roles and Mechanisms of Silibinin in Reducing Pyrazinamide- and Isoniazid-Induced Hepatocellular Damage
by: Zhang-He Goh, et al.
Published: (2020-05-01)

Silibinin effects on cognitive disorders: Hope or treatment?
by: Zahra Akhoond-Ali, et al.
Published: (2023-11-01)

Silibinin Effect on Methotrexate-Induced Hepatotoxicity in Rats
by: Emine Yanaşoğlu, et al.
Published: (2022-10-01)

Correction: A Lead-In with Silibinin Prior to Triple-Therapy Translates into Favorable Treatment Outcomes in Difficult-To-Treat HIV/Hepatitis C Coinfected Patients.
by: PLOS ONE Staff
Published: (2015-01-01)

Induced Packaging of Cellular MicroRNAs into HIV-1 Virions Can Inhibit Infectivity
by: Hal P. Bogerd, et al.
Published: (2017-03-01)

Silibinin ameliorates deoxycholic acid-induced pyroptosis in steatotic HepG2 cells by inhibiting NLRP3 inflammasome activation
by: Meiqing Mai, et al.
Published: (2023-09-01)

Combined treatment with silibinin and either sorafenib or gefitinib enhances their growth-inhibiting effects in hepatocellular carcinoma cells
by: Ha Ra Gu, et al.
Published: (2015-03-01)

Inhibition of TMEM16A by Natural Product Silibinin: Potential Lead Compounds for Treatment of Lung Adenocarcinoma
by: Shuai Guo, et al.
Published: (2021-04-01)

Inhibitory effect of silibinin on hepatitis B virus entry
by: Teruyuki Umetsu, et al.
Published: (2018-07-01)

Silibinin restores the sensitivity of cisplatin and taxol in A2780-resistant cell and reduces drug-induced hepatotoxicity
by: Yang Z, et al.
Published: (2019-07-01)

Quantifying the contribution of cellular proliferation to maintaining the HIV reservoir
by: A. Hill, et al.
Published: (2019-12-01)

Inhibition of Non Canonical HIV-1 Tat Secretion Through the Cellular Na+,K+-ATPase Blocks HIV-1 Infection
by: Silvia Agostini, et al.
Published: (2017-07-01)

HIV aspartyl peptidase inhibitors interfere with cellular proliferation, ultrastructure and macrophage infection of Leishmania amazonensis.
by: Lívia O Santos, et al.
Published: (2009-01-01)

Silibinin Improves the Effects of Methotrexate in Patients with Active Rheumatoid Arthritis: Pilot Clinical Study
by: Saad Abdulrahman Hussain, et al.
Published: (2016-07-01)

Combination of Silibinin and Curcumin Reduced Leptin Receptor Expression in MCF-7 Human Breast Cancer Cell Line
by: Somaye Dalimi-Asl, et al.
Published: (2020-11-01)

Lung Cancer Management with Silibinin: A Historical and Translational Perspective
by: Sara Verdura, et al.
Published: (2021-06-01)

An Overview on the Effects of Silibinin on Different MicroRNAs Expression in Cancer
by: Vahid Akbari Kordkheyli, et al.
Published: (2018-10-01)

Effect of silibinin on the hyperlipidemia in rats fed with high cholesterol diet
by: Abdullah Arpacı, et al.
Published: (2021-03-01)

Silibinin sensitizes chemo-resistant breast cancer cells to chemotherapy
by: Ommoleila Molavi, et al.
Published: (2017-01-01)

Silibinin regulates lipid metabolism and differentiation in functional human adipocytes
by: Ignazio eBarbagallo, et al.
Published: (2016-01-01)

CUL5 is required for thalidomide-dependent inhibition of cellular proliferation.
by: Bryan Kunkler, et al.
Published: (2018-01-01)

GB virus C infection is associated with altered lymphocyte subset distribution and reduced T cell activation and proliferation in HIV-infected individuals.
by: Jack T Stapleton, et al.
Published: (2012-01-01)

Pharmacological screening of silibinin for antischizophrenic activity along with its acute toxicity evaluation in experimental animals
by: Qurat Ul Ain, et al.
Published: (2023-02-01)

Silibinin Suppresses TNF-α-Induced MMP-9 Expression in Gastric Cancer Cells through Inhibition of the MAPK Pathway
by: Sung Kim, et al.
Published: (2009-10-01)